The Phase 2 clinical trial was conducted in Japan, South Korea, and Taiwan in patients with previously untreated, HER2-negative unresectable advanced or recurrent gastric cancer (including ...
Safety and efficacy evaluation of neoadjuvant chemoradiotherapy plus thymalfasin and tislelizumab for treating MSS/pMMR locally advanced rectal cancer. Single-incision laparoscopic surgery vs ...
Find the latest Otsuka Holdings Co., Ltd. (4578.T) stock quote, history, news and other vital information to help you with your stock trading and investing.
A single-institution experience of acute toxicities in patients treated with short course hypofractionated radiotherapy in locally advanced rectal cancer. This is an ASCO Meeting Abstract from the ...
ONO-4578, an EP4 antagonist, in combination with Opdivo and chemotherapy demonstrated a significant prolongation of progression-free survival compared with placebo in combination with Opdivo and ...
The Otsuka Holdings Ltd stock price today is 10,680.0 JPY. What Stock Exchange Does Otsuka Holdings Ltd (4578) Trade On? Otsuka Holdings Ltd is listed and trades on the Tokyo Stock Exchange. What Is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results